Mastocytosis: Moving the Field to Precision and Personalized Medicine

Immunol Allergy Clin North Am. 2018 Aug;38(3):xv-xvii. doi: 10.1016/j.iac.2018.05.001. Epub 2018 Jun 9.

Author

Mariana C Castells¹

Affiliation

¹ Drug Hypersensitivity and Desensitization Center, Mastoctytosis Center, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Room 5002, Boston, MA 02115, USA; 850 Boylston Street, Brookline, MA 02445, USA. Electronic address: mcastells@partners.org.

PMID: 30007470
DOI: 10.1016/j.iac.2018.05.001

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Humans
Mast Cells / physiology*
Mastocytosis / diagnosis*
Mastocytosis / drug therapy
Mastocytosis / genetics
Precision Medicine
Protein Kinase Inhibitors / therapeutic use
Proto-Oncogene Proteins c-kit / genetics
Quality of Life
Staurosporine / analogs & derivatives
Staurosporine / therapeutic use
Tryptases / genetics
Urticaria Pigmentosa / diagnosis*
Urticaria Pigmentosa / drug therapy
Urticaria Pigmentosa / genetics

Substances

Protein Kinase Inhibitors
Proto-Oncogene Proteins c-kit
Tpsab1 protein, rat
Tryptases
Staurosporine
midostaurin